A Study of AK112 in Advanced Malignant Tumors

NCT05214482 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: AK112
DRUG: AK117
DRUG: Chemotherapy

Sponsor

Akeso